CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
GW Pharmaceuticals PLC - ADR Company Snapshot
GW Pharmaceuticals PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares GW Pharmaceuticals PLC with three other miscellaneous service companies in North America: Opiant Pharmaceuticals Inc of Canada (2016 sales of 13.09 million Canadian Dollars [US$9.87 million] ), Vernalis Plc ($17.68 million of which 67% was Collaborative), and Neptune Technologies & Bioressources Inc which is based in Canada (22.63 million Canadian Dollars [US$17.06 million] ).

Sales Analysis. Sales fell dramatically in 2016: GW Pharmaceuticals PLC reported sales of $14.57 million for the fiscal year ending September of 2016. This represents a sharp decrease of 66.9% versus 2015, when the company's sales were $43.99 million.
   
   
 
  Stock Performance Chart for GW Pharmaceuticals PLC - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2016): 112.32
(Figures in U.S. Dollars)
1 Week -4.4%   13 Weeks -2.4%  
4 Weeks 35.8%   52 Weeks 34.4%  
 
GW Pharmaceuticals PLC - ADR Key Data:
  Ticker: GWPH Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 14,570,660
(Year Ending Jan 2017).
Employees: 369
  Currency: U.S. Dollars Market Cap: N/A
  Fiscal Yr Ends: September Shares Outstanding: N/A
  Share Type: Common Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.